Citations (262)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Pierre-Antoine Laurent, Daphne Morel, Lydia Meziani, Stephane Depil & Eric Deutsch. (2023) Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors. OncoImmunology 12:1.
Read now
Read now
Rong Huang, Xiaoxu Lu, Xueming Sun & Hong Ge. (2023) Clinical study on changes of peripheral blood immune function indicators in adults with newly diagnosed glioblastoma during the peri-radiotherapy period. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-23.
Read now
Read now
Luca Tagliaferri, Valentina Lancellotta, Bruno Fionda, Monica Mangoni, Calogero Casà, Alessandro Di Stefani, Monica Maria Pagliara, Andrea D’Aviero, Giovanni Schinzari, Silvia Chiesa, Ciro Mazzarella, Stefania Manfrida, Giuseppe Ferdinando Colloca, Fabio Marazzi, Alessio Giuseppe Morganti, Maria Antonietta Blasi, Ketty Peris, Giampaolo Tortora & Vincenzo Valentini. (2022) Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review. Human Vaccines & Immunotherapeutics 18:3.
Read now
Read now
Erin Crotty, Kira Downey, Lauren Ferrerosa, Catherine Flores, Bindu Hegde, Scott Raskin, Eugene Hwang, Nicholas Vitanza & Hideho Okada. (2021) Considerations when treating high-grade pediatric glioma patients with immunotherapy. Expert Review of Neurotherapeutics 21:2, pages 205-219.
Read now
Read now
Ben G.L. Vanneste, Evert J Van Limbergen, Ludwig Dubois, Iryna V. Samarska, L. Wieten, M. J.B. Aarts, T. Marcelissen & Dirk De Ruysscher. (2020) Immunotherapy as sensitizer for local radiotherapy. OncoImmunology 9:1.
Read now
Read now
Nazanin Majd & John de Groot. (2019) Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma. Expert Opinion on Pharmacotherapy 20:13, pages 1609-1624.
Read now
Read now
Anna F. Piotrowski, Thomas R. Nirschl, Esteban Velarde, Lee Blosser, Sudipto Ganguly, Kathleen H. Burns, Leo Luznik, John Wong, Charles G. Drake & Stuart A. Grossman. (2018) Systemic depletion of lymphocytes following focal radiation to the brain in a murine model. OncoImmunology 7:7.
Read now
Read now
Ayman Oweida, Shelby Lennon, Dylan Calame, Sean Korpela, Shilpa Bhatia, Jaspreet Sharma, Caleb Graham, David Binder, Natalie Serkova, David Raben, Lynn Heasley, Eric Clambey, Raphael Nemenoff & Sana D. Karam. (2017) Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma. OncoImmunology 6:10.
Read now
Read now
Lawrence Kleinberg. (2016) Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy. Patient Preference and Adherence 10, pages 2397-2406.
Read now
Read now
Tobias Weiss, Michael Weller & Patrick Roth. (2016) Immunological effects of chemotherapy and radiotherapy against brain tumors. Expert Review of Anticancer Therapy 16:10, pages 1087-1094.
Read now
Read now
Jian L. Campian, Xiaobu Ye, Malcolm Brock & Stuart A. Grossman. (2013) Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer. Cancer Investigation 31:3, pages 183-188.
Read now
Read now
Articles from other publishers (251)
Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, Glen H.J. Stevens, Hui-Kuo Shu, Tom Mikkelsen, Frank Lieberman, Glenn J. Lesser, Emerson Lee & Stuart A. Grossman. (2023) A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM). Journal of Neuro-Oncology.
Crossref
Crossref
Chris Beekman, Julia D Withrow, Camilo M Correa Alfonso, Shreya P Pathak, Robert J Dawson, Natalia Carrasco-Rojas, Andrew R Sforza, Carlos G Colon, Wesley E Bolch, Clemens Grassberger & Harald Paganetti. (2023) A stochastic model of blood flow to calculate blood dose during radiotherapy. Physics in Medicine & Biology 68:22, pages 225007.
Crossref
Crossref
Lauren Lukas, Hualin Zhang, Karen Cheng & Alan Epstein. (2023) Immune Priming with Spatially Fractionated Radiation Therapy. Current Oncology Reports.
Crossref
Crossref
Runping Hou, Wuyan Xia, Chenchen Zhang, Yan Shao, Xueru Zhu, Wen Feng, Qin Zhang, Wen Yu, Xiaolong Fu & Jun Zhao. (2023) Dosiomics and radiomics improve the prediction of post‐radiotherapy neutrophil‐lymphocyte ratio in locally advanced non‐small cell lung cancer. Medical Physics.
Crossref
Crossref
Jinliang Zhang, Li Yang, Hui Li, Jeff W. Chan, Eric K.W. Lee, Min Liu, Lingyu Ma, Qin Liu, Jian-Yue Jin, Pingfu Fu, Zhiyuan Xu & Feng-Ming (Spring) Kong. (2023) Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation. Advances in Radiation Oncology 8:6, pages 101260.
Crossref
Crossref
Lindsey Greenlund, Ryan Shanley, Kellen Mulford, Elizabeth C. Neil, Jessica Lawrence, Susan Arnold, Michael Olin, G. Elizabeth Pluhar, Andrew S. Venteicher, Clark C. Chen, Clara Ferreira, Margaret Reynolds, L. Chinsoo Cho, Christopher Wilke, B. Aika Shoo, Jianling Yuan, Kathryn Dusenbery, Lawrence R. Kleinberg, Stephanie A. Terezakis & Lindsey Sloan. (2023) Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma. Frontiers in Immunology 14.
Crossref
Crossref
Chang Ik Yoon, Jawon Hwang, Dooreh Kim, Jung Hwan Ji, Janghee Lee, Soong June Bae, Joon Jeong, Jee-Suk Chang, Yeona Cho, Hye Sun Lee, Jee Ye Kim & Sung Gwe Ahn. (2023) Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery. Scientific Reports 13:1.
Crossref
Crossref
Kelly H. Yoo, David J. Park, John H. Choi, Neelan J. Marianayagam, Michael Lim, Antonio Meola & Steven D. Chang. (2023) Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases. Frontiers in Oncology 13.
Crossref
Crossref
Harald Paganetti. (2023) A review on lymphocyte radiosensitivity and its impact on radiotherapy. Frontiers in Oncology 13.
Crossref
Crossref
Ihsuan Tseng, Fangfang Li, Dashan Ai, Yun Chen, Yang Xu, Lu Yu, Shengnan Hao, Hongcheng Zhu, Jiaying Deng, Qi Liu, Fan Pan, Fengtao Su & Kuaile Zhao. (2023) Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials. The Oncologist 28:8, pages e645-e652.
Crossref
Crossref
Shang CaiYawen FanQi Guo, Yanze SunPeifeng ZhaoYe TianQiuhong Fan. (2023) Impact of Radiation Dose to Circulating Immune Cells on Tumor Control and Survival in Esophageal Cancer. Cancer Biotherapy and Radiopharmaceuticals 38:6, pages 380-387.
Crossref
Crossref
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman & Silvia C. Formenti. (2023) Emerging evidence for adapting radiotherapy to immunotherapy. Nature Reviews Clinical Oncology 20:8, pages 543-557.
Crossref
Crossref
Lucas McCullum, Jungwook Shin, Stella Xing, Chris Beekman, Jan Schuemann, Theodore Hong, Dan Duda, Radhe Mohan, Steven H. Lin, Camilo M. Correa-Alfonso, Sean Domal, Julia Withrow, Wesley Bolch, Harald Paganetti & Clemens Grassberger. (2023) Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations. International Journal of Radiation Oncology*Biology*Physics 116:5, pages 1226-1233.
Crossref
Crossref
Xianyan Chen, Xiaoman Tian, Xuanwei Zhang, Qianyue Deng, Min Wang, Xiaojuan Zhou, Yong Xu, Lin Zhou, Bingwen Zou, Yongmei Liu, Rui Ao, You Lu & Youling Gong. (2023) Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy. Thoracic Cancer.
Crossref
Crossref
Abdelkhalek Hammi. (2023) 4D dosimetric-blood flow model: impact of prolonged fraction delivery times of IMRT on the dose to the circulating lymphocytes. Physics in Medicine & Biology 68:14, pages 145017.
Crossref
Crossref
Luc Ollivier, Camille Moreau Bachelard, Emmanuelle Renaud, Estelle Dhamelincourt & Francois Lucia. (2023) The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review. Frontiers in Immunology 14.
Crossref
Crossref
Shay Sharon, Narmeen Daher-Ghanem, Deema Zaid, Michael J. Gough & Nataly Kravchenko-Balasha. (2023) The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer. Frontiers in Oral Health 4.
Crossref
Crossref
Lorea Iturri, Annaïg Bertho, Charlotte Lamirault, Marjorie Juchaux, Cristèle Gilbert, Julie Espenon, Catherine Sebrie, Laurène Jourdain, Frédéric Pouzoulet, Pierre Verrelle, Ludovic De Marzi & Yolanda Prezado. (2023) Proton FLASH Radiation Therapy and Immune Infiltration: Evaluation in an Orthotopic Glioma Rat Model. International Journal of Radiation Oncology*Biology*Physics 116:3, pages 655-665.
Crossref
Crossref
Emily P. Vonderhaar, Michael B. Dwinell & Brian T. Craig. (2023) Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches. Frontiers in Immunology 14.
Crossref
Crossref
Bouthaina Dabaja & Michael Spiotto. (2023) Radiation for hematologic malignancies: from cell killing to immune cell priming. Frontiers in Oncology 13.
Crossref
Crossref
Joris B. W. Elbers, Pascal A. Gunsch, Reno Debets, Stijn Keereweer, Esther van Meerten, Jaap Zindler, Yvette van Norden, Mischa S. Hoogeman, Gerda M. Verduijn, Michiel Kroesen & Remi A. Nout. (2023) HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial. BMC Cancer 23:1.
Crossref
Crossref
Xinyu Fan, Linlin Yang, Wenru Qin, Bing Zou, Bingjie Fan, Shijiang Wang & Linlin Wang. (2023) Prophylactic cranial irradiation-related lymphopenia affects survival in patients with limited-stage small cell lung cancer. Heliyon 9:6, pages e16483.
Crossref
Crossref
Jianjian Qiu, Hancui Lin, Dongmei Ke, Yilin Yu, Jiaying Xu, Hejin Qiu, Qunhao Zheng, Hui Li, Hongying Zheng, Lingyun Liu, Zhiping Wang, Qiwei Yao & Jiancheng Li. (2023) Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma. Frontiers in Immunology 14.
Crossref
Crossref
Yu‐Jung Lin, Yu‐Mei Kang, Yuan‐Hung Wu, Yi‐Wei Chen & Yu‐Wen Hu. (2023) Lymphocytopenia and survival after whole‐brain radiotherapy in patients with small‐cell lung cancer. Thoracic Cancer 14:14, pages 1268-1275.
Crossref
Crossref
Kentaro Nishioka, Shuhei Takahashi, Takashi Mori, Yusuke Uchinami, Shigeru Yamaguchi, Manabu Kinoshita, Masaaki Yamashina, Hajime Higaki, Katsuya Maebayashi & Hidefumi Aoyama. (2023) The need of radiotherapy optimization for glioblastomas considering immune responses. Japanese Journal of Radiology.
Crossref
Crossref
M. Césaire, A. Rambeau, F. Cherifi, B. Géry, A. Johnson, M. Nacher & J. Thariat. (2023) Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancers. Cancer/Radiothérapie 27:2, pages 145-153.
Crossref
Crossref
Masatoshi Nakamura, Hitoshi Ishikawa, Kayoko Ohnishi, Yutarou Mori, Keiichiro Baba, Kensuke Nakazawa, Toshihiro Shiozawa, Ikuo Sekine, Kazushi Maruo, Toshiyuki Okumura & Hideyuki Sakurai. (2023) Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer. Journal of Radiation Research 64:2, pages 438-447.
Crossref
Crossref
Yasmine El Houat, Christophe Massard, Veronique Quillien, Renaud de Crevoisier & Joël Castelli. (2023) Meta-analysis and Critical Review: Association Between Radio-induced Lymphopenia and Overall Survival in Solid Cancers. Advances in Radiation Oncology 8:2, pages 101038.
Crossref
Crossref
Thao-Nguyen Pham, Julie Coupey, Serge M. Candeias, Viktoriia Ivanova, Samuel Valable & Juliette Thariat. (2023) Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Crossref
Min Kyu Kang. (2023) Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer. World Journal of Gastroenterology 29:6, pages 1011-1025.
Crossref
Crossref
Maria Manuela Rosado & Claudio Pioli. (2023) Radiotherapy, PARP Inhibition, and Immune-Checkpoint Blockade: A Triad to Overcome the Double-Edged Effects of Each Single Player. Cancers 15:4, pages 1093.
Crossref
Crossref
Annaig Bertho, Lorea Iturri, Elise Brisebard, Marjorie Juchaux, Cristèle Gilbert, Ramon Ortiz, Catherine Sebrie, Laurene Jourdain, Charlotte Lamirault, Gabriel Ramasamy, Frédéric Pouzoulet & Yolanda Prezado. (2023) Evaluation of the Role of the Immune System Response After Minibeam Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 115:2, pages 426-439.
Crossref
Crossref
Subhajit Ghosh, Jiayi Huang, Matthew Inkman, Jin Zhang, Sukrutha ThotalaEkaterina Tikhonova, Natalia Miheecheva, Felix Frenkel, Ravshan Ataullakhanov, Xiaowei Wang, David DeNardo, Dennis HallahanDinesh Thotala. (2023) Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma. Science Translational Medicine 15:680.
Crossref
Crossref
Bao-Zhong Zhang, Yang Li, Li-Ming Xu, Yan-Lan Chai, Chao Qu, Yuan-Jie Cao, Jing Wang, Hai-Ling Hou & Jiaqi Zhang. (2023) The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer. Radiation Oncology 18:1.
Crossref
Crossref
Siming Gao, Wenjie Tang, Bingli Zuo, Lianne Mulvihill, Jinming Yu & Yishan Yu. (2023) The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy. Frontiers in Oncology 12.
Crossref
Crossref
Nalee Kim, Do Hoon Lim, Jung Won Choi, Jung-Il Lee, Doo-Sik Kong, Ho Jun Seol & Do-Hyun Nam. (2023) Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma. Yonsei Medical Journal 64:2, pages 94.
Crossref
Crossref
A. Helm, C. Totis, M. Durante & C. Fournier. 2023. Ionizing Radiation and the Immune Response - Part A. Ionizing Radiation and the Immune Response - Part A
1
36
.
Gowoon Yang, Jee Suk Chang, Jeong Eun Choi, Eun Sil Baek, Seung-Seob Kim, Hwa Kyung Byun, Yeona Cho, Woong Sub Koom, Seung Yoon Yang, Byung Soh Min & Sang Joon Shin. (2022) Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer. Radiation Oncology 17:1.
Crossref
Crossref
Amelia Barcellini, Giulia Fontana, Daria Maria Filippini, Sara Ronchi, Maria Bonora, Barbara Vischioni, Rossana Ingargiola, Anna Maria Camarda, Pierre Loap, Nadia Facchinetti, Lisa Licitra, Guido Baroni & Ester Orlandi. (2022) Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy. Radiotherapy and Oncology 177, pages 143-151.
Crossref
Crossref
BhanuPrasad Venkatesulu, Prashanth Giridhar, Lincoln Pujari, Brian Chou, Jae Han Lee, Alec M. Block, Rituraj Upadhyay, James S. Welsh, Matthew M. Harkenrider, Sunil Krishnan, Vivek Verma, Cheng En Hsieh, Satyajit Pradhan, William SmallJrJr & Abhishek A. Solanki. (2022) Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy. Radiotherapy and Oncology 177, pages 81-94.
Crossref
Crossref
Wonmo Sung & Byungchul Cho. (2022) Modeling of radiation effects to immune system: a review. Journal of the Korean Physical Society 81:11, pages 1013-1019.
Crossref
Crossref
Eva Bogaerts, Ellina Macaeva, Sofie Isebaert & Karin Haustermans. (2022) Potential Molecular Mechanisms behind the Ultra-High Dose Rate “FLASH” Effect. International Journal of Molecular Sciences 23:20, pages 12109.
Crossref
Crossref
Nuo-Han Wang, Xin Zhang, Jiang-Dong Sui, Ying Wang, Yong-Zhong Wu, Qian-Qian Lei, Hong-Lei Tu, Li-Na Yang, Yun-Chang Liu, Meng-Qi Yang, Hao-Nan Yang, Dan Li & Zheng Lei. (2022) Radiation-induced eosinophil increase ratio predicts patient outcomes in non-small celllung cancer. Frontiers in Oncology 12.
Crossref
Crossref
Supriya Mallick, Anjali V.R, Prashanth Giridhar, Rituraj Upadhyay, Byung-Kyu Kim, Amrish Sharma, Hagar Elghazawy, Thiraviyam Elumalai, Vinod Solipuram, Cheng En Hsieh, Courtney Hentz, Abhishek A. Solanki, Jing Li, Dennis Pai Chan, Emily Ness, Bhanu Prasad Venkatesulu & David R. Grosshans. (2022) A Systematic Review and Meta-analysis of the Impact of Radiation-Related Lymphopenia on Outcomes in High-Grade Gliomas. South Asian Journal of Cancer 11:04, pages 361-369.
Crossref
Crossref
Mehdi Karimi-Shahri, Malihe Khorramdel, Sara Zarei, Fatemeh Attarian, Pedram Hashemian & Hossein Javid. (2022) Glioblastoma, an opportunity T cell trafficking could bring for the treatment. Molecular Biology Reports 49:10, pages 9863-9875.
Crossref
Crossref
Wenjie Ni, Zefen Xiao, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang & Jima Lv. (2022) Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A post hoc analysis of a randomized controlled trial. Frontiers in Oncology 12.
Crossref
Crossref
Jaesung Heo & O Kyu Noh. (2022) Prognostic Significance of Initial Absolute Lymphocyte Count in Adjuvant Radiotherapy for Pancreatic Adenocarcinoma. Biomedicines 10:9, pages 2190.
Crossref
Crossref
Michael J. Gough & Marka R. Crittenden. (2022) The paradox of radiation and T cells in tumors. Neoplasia 31, pages 100808.
Crossref
Crossref
Wang Jing, Ting Xu, Lirong Wu, Pablo B. Lopez, Clemens Grassberger, Susannah G. Ellsworth, Radhe Mohan, Brian P. Hobbs, George R. Blumenschein, Janet Tu, Mehmet Altan, Percy Lee, Zhongxing Liao & Steven H. Lin. (2022) Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC. JTO Clinical and Research Reports 3:9, pages 100391.
Crossref
Crossref
Shing Fung Lee, Pui Lam Yip, Aray Wong, Francesca Ng, Vicky Koh, Lea Choung Wong, Hollis Luk, Chuk Kwan Ng, Francis Ann Shing Lee & Harvey J. Mamon. (2022) Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer. Clinical and Translational Radiation Oncology 36, pages 83-90.
Crossref
Crossref
Susannah G. Ellsworth, Anirudh Yalamanchali, Tim Lautenschlaeger, Stuart A. Grossman, Clemens Grassberger, Steven H. Lin & Radhe Mohan. (2022) Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation Therapy. Advances in Radiation Oncology 7:5, pages 100959.
Crossref
Crossref
April K. Vassantachart, Derrick Lock, Hye Ri Han & Jason C. Ye. (2022) Stereotactic Body Radiation in Breast Cancer — Definitive, Oligometastatic, and Beyond. Current Breast Cancer Reports 14:3, pages 53-64.
Crossref
Crossref
Luc Ollivier, Charles Orione, Paul Bore, Laurent Misery, Delphine Legoupil, Jean-Christophe Leclere, Anne Coste, Gilles Girault, Iona Sicard-Cras, Clemence Kacperek, Francois Lucia, Dinu Stefan, François Thillays, Emmanuel Rio, Paul Lesueur, Christian Berthou, Dominique Heymann, Stéphane Champiat, Stéphane Supiot, Loig Vaugier & William Kao. (2022) Abscopal Response in Metastatic Melanoma: Real-World Data of a Retrospective, Multicenter Study. Cancers 14:17, pages 4213.
Crossref
Crossref
Jea Giezl N. Solidum, Raniv D. Rojo, Jennifer Y. Wo & Edward Christopher Dee. (2022) Proton Beam Therapy for Esophageal Cancer. Cancers 14:16, pages 4045.
Crossref
Crossref
M. Baré, S. Poeta, P. Fernandes, Y. Jourani, F-X. Otte, S. Van Brussel, D. Van Gestel & R. Van den Begin. (2022) Lymphocyte-sparing pelvic radiotherapy for prostate cancer: an in-silico study. Physics and Imaging in Radiation Oncology.
Crossref
Crossref
Thomas Friedrich, Michael Scholz & Marco Durante. (2022) A Predictive Biophysical Model of the Combined Action of Radiation Therapy and Immunotherapy of Cancer. International Journal of Radiation Oncology*Biology*Physics 113:4, pages 872-884.
Crossref
Crossref
Hao Yu, Fang Chen, Ka-On Lam, Li Yang, Yang Wang, Jian-Yue Jin, Aya EI Helali & Feng-Ming (Spring) Kong. (2022) Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach. Frontiers in Immunology 13.
Crossref
Crossref
Dongjun Dai, Qiaoying Tian, Genhua Yu, Yongjie Shui, Hao Jiang & Qichun Wei. (2022) Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis. Cancers 14:12, pages 3024.
Crossref
Crossref
Dooreh Kim, Soong June Bae, Sung Gwe Ahn, Joon Jeong, Seho Park, Woo-Chan Park, Goeun Park, Sujee Lee & Chang Ik Yoon. (2022) RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis. Breast Cancer Research and Treatment 193:3, pages 637-647.
Crossref
Crossref
Radhe Mohan. (2022) A review of proton therapy – Current status and future directions. Precision Radiation Oncology 6:2, pages 164-176.
Crossref
Crossref
Lourdes Cruz-Garcia, Farah Nasser, Grainne O’Brien, Jakub Grepl, Volodymyr Vinnikov, Viktor Starenkiy, Sergiy Artiukh, Svetlana Gramatiuk & Christophe Badie. (2022) Transcriptional Dynamics of DNA Damage Responsive Genes in Circulating Leukocytes during Radiotherapy. Cancers 14:11, pages 2649.
Crossref
Crossref
Sherif G. ShaabanMB ChBMB ChB, Daniel EbnerMD, MPHMD, MPH & Osama MohamadMD, PhDMD, PhD. 2022. Principles and Practice of Particle Therapy. Principles and Practice of Particle Therapy
151
163
.
Léa Vazquez & Antoine Arnaud. 2022. Metastasis. Metastasis
109
116
.
Danyi Zhai, Dandan An, Chao Wan & Kunyu Yang. (2022) Radiotherapy: Brightness and darkness in the era of immunotherapy. Translational Oncology 19, pages 101366.
Crossref
Crossref
Willeke Danckaert, Mathieu Spaas, Katrien Vandecasteele, Carlos De Wagter & Piet Ost. (2022) Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: A systematic review of the literature. Radiotherapy and Oncology 170, pages 64-69.
Crossref
Crossref
Roberto Mapelli, Chiara Julita, Sofia Paola Bianchi, Nicolò Gallina, Raffaella Lucchini, Martina Midulla, Flavia Puci, Jessica Saddi, Sara Trivellato, Denis Panizza, Elena De Ponti & Stefano Arcangeli. (2021) Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy. Strahlentherapie und Onkologie 198:5, pages 448-457.
Crossref
Crossref
Fang Chen, Jian-Yue Jin, Timothy S.K. Hui, Haiman Jing, Hong Zhang, Yaqing Nong, Ying Han, Weili Wang, Lingyu Ma, Fan Yi, Qingqing Chen, Yongsheng Zhang, Pingfu Fu, Li Yang, Zhiyuan Xu & Feng-Ming Spring Kong. (2022) Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Yeona Cho, Yejin Kim, Ibrahim Chamseddine, Won Hee Lee, Hye Ryun Kim, Ik Jae Lee, Min Hee Hong, Byung Chul Cho, Chang Geol Lee, Seungryong Cho, Jin Sung Kim, Hong In Yoon & Clemens Grassberger. (2022) Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy. Radiotherapy and Oncology 168, pages 1-7.
Crossref
Crossref
Yajing Zhang, Yujie Zhu, Jiaqi Wang, Yi Xu, Zekun Wang, Yang Liu, Xuebing Di, Lin Feng & Ye Zhang. (2021) A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma. Cancer Immunology, Immunotherapy 71:3, pages 675-688.
Crossref
Crossref
Anna A. Friedl, Kevin M. Prise, Karl T. Butterworth, Pierre Montay‐Gruel & Vincent Favaudon. (2021) Radiobiology of the FLASH effect. Medical Physics 49:3, pages 1993-2013.
Crossref
Crossref
Igor Bryukhovetskiy. (2022) Cell‑based immunotherapy of glioblastoma multiforme (Review). Oncology Letters 23:4.
Crossref
Crossref
Siqi Liang, Guangming Zhou & Wentao Hu. (2022) Research Progress of Heavy Ion Radiotherapy for Non-Small-Cell Lung Cancer. International Journal of Molecular Sciences 23:4, pages 2316.
Crossref
Crossref
Yongchao Zhang, Shichao Chen, Hualei Chen, Shanshan Chen, Zhen Li, Enshan Feng & Wei Li. (2022) Prognostic Value and Risk Factors of Treatment-Related Lymphopenia in Malignant Glioma Patients Treated With Chemoradiotherapy: A Systematic Review and Meta-Analysis. Frontiers in Neurology 12.
Crossref
Crossref
Qianqian Zhao, Tingting Li, Shisuo Du, Jian He & Zhaochong Zeng. (2022) Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. Technology in Cancer Research & Treatment 21, pages 153303382211122.
Crossref
Crossref
Casey W. Williamson, Igor Sirák, Ronghui Xu, Lorraine Portelance, Lichun Wei, Rafal Tarnawski, Umesh Mahantshetty, Elena S. Heide, Catheryn M. Yashar, Michael T. McHale, Walter Bosch, Jessica Lowenstein, Cheryl C. Saenz, Steve Plaxe, Ramez Eskander, John Einck, Arno J. Mundt, Jyoti Mayadev & Loren K. Mell. (2022) Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial. International Journal of Radiation Oncology*Biology*Physics 112:1, pages 169-178.
Crossref
Crossref
Annaig Bertho, Lorea Iturri & Yolanda Prezado. 2022.
Susannah G. Ellsworth & Stuart A. Grossman. 2022. Immunotherapeutic Strategies for the Treatment of Glioma. Immunotherapeutic Strategies for the Treatment of Glioma
1
17
.
Molly Blau, Stephanie K. Schaub & Ralph P. Ermoian. 2022. Radiation Therapy for Sarcomas and Skin Cancers. Radiation Therapy for Sarcomas and Skin Cancers
111
137
.
Zsuzsa S. Kocsis, Tibor Major, Csilla Pesznyák, Dalma Mihály, Gábor Stelczer, Márta Kun-Gazda, Gyöngyi Farkas, Gábor Székely, Péter Ágoston, Kliton Jorgo, László Gesztesi, Csaba Polgár & Zsolt Jurányi. (2021) Relationship between biodosimetric parameters and treatment volumes in three types of prostate radiotherapy. Scientific Reports 11:1.
Crossref
Crossref
Jian-Yue Jin, Chen Hu, Ying Xiao, Hong Zhang, Rebecca Paulus, Susannah G. Ellsworth, Steven E. Schild, Jeffrey A. Bogart, Michael Chris Dobelbower, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Cliff Robinson, Joel S. Greenberger, Christopher Koprowski, Mitchell Machtay, Walter Curran, Hak Choy, Jeffrey D. Bradley & Feng-Ming (Spring) Kong. (2021) Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617. Cancers 13:24, pages 6193.
Crossref
Crossref
Jing Xi, Bilal Hassan, Ruth G. N. Katumba, Karam Khaddour, Akshay Govindan, Jingqin Luo, Jiayi Huang & Jian L. Campian. (2021) The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma. BMC Cancer 21:1.
Crossref
Crossref
George Sgouros, Wesley E. Bolch, Arturo Chiti, Yuni K. Dewaraja, Dimitris Emfietzoglou, Robert F. Hobbs, Mark Konijnenberg, Katarina Sjögreen-Gleisner, Lidia Strigari, Tzu-Chen Yen & Roger W. Howell. (2022) ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy. Journal of the ICRU 21:1, pages 1-212.
Crossref
Crossref
Giuseppe Carlo Iorio, Benjamin Oren Spieler, Umberto Ricardi & Alan Dal Pra. (2021) The Impact of Pelvic Nodal Radiotherapy on Hematologic Toxicity: A Systematic Review with Focus on Leukopenia, Lymphopenia and Future Perspectives in Prostate Cancer Treatment. Critical Reviews in Oncology/Hematology 168, pages 103497.
Crossref
Crossref
Xiaohui Wang, Hui Luo, Xiaoli Zheng & Hong Ge. (2021) FLASH radiotherapy: Research process from basic experimentation to clinical application. Precision Radiation Oncology 5:4, pages 259-266.
Crossref
Crossref
Pim J.J. Damen, Tiuri E. Kroese, Richard van Hillegersberg, Ewoud Schuit, Max Peters, Joost J.C. Verhoeff, Steven H. Lin & Peter S.N. van Rossum. (2021) The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis. International Journal of Radiation Oncology*Biology*Physics 111:4, pages 936-948.
Crossref
Crossref
Re-I Chin, Joshua P. Schiff, Randall J. Brenneman, Hiram A. Gay, Wade L. Thorstad & Alexander J. Lin. (2021) A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy. Cancers 13:21, pages 5269.
Crossref
Crossref
Hwa Kyung Byun, Seung Yeun Chung, Kyoung-Jin Kim & Jinsil Seong. (2021) Role of Interleukin-7 in the Development of and Recovery from Radiation-Induced Lymphopenia: A Post-hoc Analysis of a Prospective Cohort. Cancer Research and Treatment 53:4, pages 962-972.
Crossref
Crossref
Saba Ebrahimi, Gino Lim, Amy Liu, Steven H. Lin, Susannah G. Ellsworth, Clemens Grassberger, Radhe Mohan & Wenhua Cao. (2021) Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients. International Journal of Particle Therapy 8:2, pages 17-27.
Crossref
Crossref
Yishan Yu, Pingfu Fu, Jian-Yue Jin, Siming Gao, Weili Wang, Mitchell Machtay, Linlin Wang, Feng-Ming (Spring) Kong & Jinming Yu. (2021) Impact of effective dose to immune cells (EDIC) on lymphocyte nadir and survival in limited-stage SCLC. Radiotherapy and Oncology 162, pages 26-33.
Crossref
Crossref
F. Le Tinier, L. Padovani & B. Vandendorpe. (2021) Traitements par radiothérapie stéréotaxique : indications et situations cliniques particulières. Revue des Maladies Respiratoires Actualités 13:2, pages 2S81-2S88.
Crossref
Crossref
Jungwook Shin, Shu Xing, Lucas McCullum, Abdelkhalek Hammi, Jennifer Pursley, Camilo A Correa, Julia Withrow, Sean Domal, Wesley Bolch, Harald Paganetti & Clemens Grassberger. (2021) HEDOS—a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations. Physics in Medicine & Biology 66:16, pages 164001.
Crossref
Crossref
Hiromitsu Iwata & Yuta Shibamoto. (2021) FLASH RadiotherapyFLASH Radiotherapy. RADIOISOTOPES 70:4, pages 279-289.
Crossref
Crossref
David S. Lakomy, Juliana Wu, Dorothy Lombe, Emmanouil Papasavvas, Susan Citonje Msadabwe, Yimin Geng, Luis J. Montaner, Elizabeth Chiao & Lilie L. Lin. (2021) Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review. Cancer Medicine 10:13, pages 4206-4220.
Crossref
Crossref
Hiroshi Doi & Kozo Kuribayashi. 2021. Lung Cancer - Modern Multidisciplinary Management. Lung Cancer - Modern Multidisciplinary Management.
Mauricio E. Gamez & Daniel J. Ma. (2021) Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer. International Journal of Particle Therapy 8:1, pages 223-233.
Crossref
Crossref
Jonathan Khalifa, Julien Mazieres, Carlos Gomez-Roca, Maha Ayyoub & Elizabeth Cohen-Jonathan Moyal. (2021) Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?. Frontiers in Oncology 11.
Crossref
Crossref
Rituraj Upadhyay, Bhanu Prasad Venkatesulu, Prashanth Giridhar, B.K. Kim, Amrish Sharma, Hagar Elghazawy, Bhaswanth Dhanireddy, Thiraviyam Elumalai, Supriya Mallick & Matthew Harkenrider. (2021) Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis. Radiotherapy and Oncology 157, pages 225-233.
Crossref
Crossref
Hwa Kyung Byun, Kyoung-Jin Kim, Su Chul Han & Jinsil Seong. (2021) Effect of Interleukin-7 on Radiation-Induced Lymphopenia and Its Antitumor Effects in a Mouse Model. International Journal of Radiation Oncology*Biology*Physics 109:5, pages 1559-1569.
Crossref
Crossref
Penny Q. Fang, Jillian R. Gunther, Susan Y. Wu, Bouthaina S. Dabaja, Loretta J. Nastoupil, Sairah Ahmed, Sattva S. Neelapu & Chelsea C. Pinnix. (2021) Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy. Frontiers in Oncology 11.
Crossref
Crossref
Yu-Chieh Ho, Yuan-Chun Lai, Hsuan-Yu Lin, Ming-Hui Ko, Sheng-Hung Wang, Shan-Jun Yang, Po-Ju Lin, Tsai-Wei Chou, Li-Chung Hung, Chia-Chun Huang, Tung-Hao Chang, Jhen-Bin Lin & Jin-Ching Lin. (2021) Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy. Scientific Reports 11:1.
Crossref
Crossref
Thomas Friedrich, Nicholas Henthorn & Marco Durante. (2021) Modeling Radioimmune Response—Current Status and Perspectives. Frontiers in Oncology 11.
Crossref
Crossref
Boyuan Huang, Xuesong Li, Yuntao Li, Jin Zhang, Zhitao Zong & Hongbo Zhang. (2021) Current Immunotherapies for Glioblastoma Multiforme. Frontiers in Immunology 11.
Crossref
Crossref
Harald Paganetti, Chris Beltran, Stefan Both, Lei Dong, Jacob Flanz, Keith Furutani, Clemens Grassberger, David R Grosshans, Antje-Christin Knopf, Johannes A Langendijk, Hakan Nystrom, Katia Parodi, Bas W Raaymakers, Christian Richter, Gabriel O Sawakuchi, Marco Schippers, Simona F Shaitelman, B K Kevin Teo, Jan Unkelbach, Patrick Wohlfahrt & Tony Lomax. (2021) Roadmap: proton therapy physics and biology. Physics in Medicine & Biology 66:5, pages 05RM01.
Crossref
Crossref
Nalee Kim, Jae Myoung Noh, Woojin Lee, Byoungsuk Park, Heejoo Park, Ji Young Park & Hongryull Pyo. (2021) Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy. Radiotherapy and Oncology 156, pages 166-173.
Crossref
Crossref
Kevin X. Liu, Myrsini Ioakeim-Ioannidou, Matthew S. Susko, Avani D. Rao, Beow Y. Yeap, Antoine M. Snijders, Matthew M. Ladra, Jennifer Vogel, Cierra Zaslowe-Dude, Karen J. Marcus, Torunn I. Yock, Clemens Grassberger, Steve E. Braunstein, Daphne A. Haas-Kogan, Stephanie A. Terezakis & Shannon M. MacDonald. (2021) A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma. International Journal of Radiation Oncology*Biology*Physics 109:3, pages 726-735.
Crossref
Crossref
Jiayi Huang & Minesh Mehta. (2021) Can proton therapy reduce radiation-related lymphopenia in glioblastoma?. Neuro-Oncology 23:2, pages 179-181.
Crossref
Crossref
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, Jennie W Taylor, Alissa A Thomas, Jeffrey S Wefel, Scott L Coven, Alvina A Acquaye, Chas Haynes, Sameer Agnihotri, Michael Lim, Katherine B Peters, Erik P Sulman, Joanne T Salcido, Nicholas A Butowski, Shawn Hervey-Jumper, Alireza Mansouri, Kathy R Oliver, Alyx B Porter, Farshad Nassiri, David Schiff, Erin M Dunbar, Monika E Hegi, Terri S Armstrong, Martin J van den Bent, Susan M Chang, Gelareh Zadeh & Milan G Chheda. (2021) The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment. Neuro-Oncology Advances 3:1.
Crossref
Crossref
Xiaoxue Xie, Steven H. Lin, James W. Welsh, Xiong Wei, Hekun Jin, Radhe Mohan, Zhongxing Liao & Ting Xu. (2021) Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes. Radiotherapy and Oncology 154, pages 187-193.
Crossref
Crossref
Anirudh Yalamanchali, Hong Zhang, Ke Colin Huang, Radhe Mohan, Steven H. Lin, Cong Zhu, Stuart A. Grossman, Jian-Yue Jin & Susannah G. Ellsworth. (2021) Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal Malignancies. Advances in Radiation Oncology 6:1, pages 100545.
Crossref
Crossref
David Olayinka Kamson & Stuart Grossman. 2021. Neuro-Oncology for the Clinical Neurologist. Neuro-Oncology for the Clinical Neurologist
153
171
.
Hwa Kyung Byun & Jinsil Seong. 2021. Radiotherapy of Liver Cancer. Radiotherapy of Liver Cancer
317
324
.
Claudio Fiorino, Robert Jeraj, Catharine H. Clark, Cristina Garibaldi, Dietmar Georg, Ludvig Muren, Wouter van Elmpt, Thomas Bortfeld & Nuria Jornet. (2020) Grand challenges for medical physics in radiation oncology. Radiotherapy and Oncology 153, pages 7-14.
Crossref
Crossref
Giuseppe Carlo Iorio, Umberto Ricardi & Alan Dal Pra. (2020) Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic. Frontiers in Oncology 10.
Crossref
Crossref
Joshua L. Anderson, Neil B. Newman, Chelsea Anderson, Alexander D. Sherry, Adam D. Yock & Evan C. Osmundson. (2020) Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer. Radiotherapy and Oncology 152, pages 169-176.
Crossref
Crossref
Wonmo Sung, Clemens Grassberger, Aimee Louise McNamara, Lucas Basler, Stefanie Ehrbar, Stephanie Tanadini-Lang, Theodore S. Hong & Harald Paganetti. (2020) A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy. Radiotherapy and Oncology 151, pages 73-81.
Crossref
Crossref
Dawei Chen, Roshal R. Patel, Vivek Verma, Rishab Ramapriyan, Hampartsoum B. Barsoumian, Maria Angelica Cortez & James W. Welsh. (2020) Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy. Radiotherapy and Oncology 150, pages 114-120.
Crossref
Crossref
Guang-Yi Sun, Shu-Lian Wang, Yong-Wen Song, Jing Jin, Wei-Hu Wang, Yue-Ping Liu, Hua Ren, Hui Fang, Yu Tang, Xu-Ran Zhao, Yu-Chun Song, Zi-Hao Yu, Xin-Fan Liu & Ye-Xiong Li. (2020) Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 108:1, pages 277-285.
Crossref
Crossref
Tsz Him So, Sik Kwan Chan, Wing Lok Chan, Horace Choi, Chi Leung Chiang, Victor Lee, Tai Chung Lam, Ian Wong, Simon Law, Dora Kwong, Feng Ming (Spring) Kong, Jian Yue Jin & Ka On Lam. (2020) Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma. Advances in Radiation Oncology 5:5, pages 880-888.
Crossref
Crossref
Corrine Ying Xuan Chua, Jeremy Ho, Sandra Demaria, Mauro Ferrari & Alessandro Grattoni. (2020) Emerging Technologies for Local Cancer Treatment. Advanced Therapeutics 3:9.
Crossref
Crossref
Rupesh Kotecha & Minesh P Mehta. (2020) Extreme hypofractionation for newly diagnosed glioblastoma: rationale, dose, techniques, and outcomes. Neuro-Oncology 22:8, pages 1062-1064.
Crossref
Crossref
Melissa Azoulay, Steven D Chang, Iris C Gibbs, Steven L Hancock, Erqi L Pollom, Griffith R Harsh, John R Adler, Ciara Harraher, Gordon Li, Melanie Hayden Gephart, Seema Nagpal, Reena P Thomas, Lawrence D Recht, Lisa R Jacobs, Leslie A Modlin, Jacob Wynne, Kira Seiger, Dylann Fujimoto, Melissa Usoz, Rie von Eyben, Clara Y H Choi & Scott G Soltys. (2020) A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes. Neuro-Oncology 22:8, pages 1182-1189.
Crossref
Crossref
Andrew J. Johnsrud, Samir V. Jenkins, A. Jamshidi-Parsian, Charles M. Quick, Edvaldo P. Galhardo, Ruud P.M. Dings, Kieng B. Vang, Ganesh Narayanasamy, Issam Makhoul & Robert J. Griffin. (2020) Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations. Radiation Research 194:6.
Crossref
Crossref
Jian-Yue Jin, Anxin Gu, Weili Wang, Nancy L. Oleinick, Mitchell Machtay & Feng-Ming (Spring) Kong. (2020) Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?. Radiotherapy and Oncology 149, pages 55-62.
Crossref
Crossref
Magalie Dosset, Elodie Lauret-Marie Joseph, Thaiz Rivera Vargas & Lionel Apetoh. (2020) Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors. Cells 9:7, pages 1727.
Crossref
Crossref
Chang Ik Yoon, Dooreh Kim, Sung Gwe Ahn, Soong June Bae, Chihwan Cha, Soeun Park, Seho Park, Seung Il Kim, Hye Sun Lee, Ju Young Park & Joon Jeong. (2020) Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer. Cancers 12:7, pages 1896.
Crossref
Crossref
Mathieu Cesaire, Brigitte Le Mauff, Audrey Rambeau, Olivier Toutirais & Juliette Thariat. (2020) Mécanismes de la lymphopénie radio-induite et implications thérapeutiques. Bulletin du Cancer 107:7-8, pages 813-822.
Crossref
Crossref
Shang-Jui Wang, Sachin R Jhawar, Zorimar Rivera-Nunez, Ann W Silk, John Byun, Eric Miller, Dukagjin Blakaj, Rahul R Parikh, Joseph Weiner & Sharad Goyal. (2020) The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients. Cureus.
Crossref
Crossref
Michael S. Kent, Shaheen Emami, Rob Rebhun, Alain Theon, Katherine Hansen & Ellen Sparger. (2019) The effects of local irradiation on circulating lymphocytes in dogs receiving fractionated radiotherapy. Veterinary and Comparative Oncology 18:2, pages 191-198.
Crossref
Crossref
Changqing Xie, Austin G. Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry-Hrones, Melissa Walker, Cecilia Monge Bonilla, Bradford J. Wood, Deborah E. Citrin, Elizabeth M. Gil Ramirez, Freddy E. Escorcia, Bernadette Redd, Jonathan M. Hernandez, Jeremy L. Davis, Billel Gasmi, David Kleiner, Seth M. Steinberg, Jennifer C. Jones & Tim F. Greten. (2020) Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 26:10, pages 2318-2326.
Crossref
Crossref
Cai Xu, Jian-Yue Jin, Ming Zhang, Amy Liu, Jun Wang, Radhe Mohan, Fengming (Spring) Kong & Steven H. Lin. (2020) The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy. Radiotherapy and Oncology 146, pages 180-186.
Crossref
Crossref
Zhenwei Zou, Stephen R. Bowen, Hannah M.T. Thomas, Balu Krishna Sasidharan, Ramesh Rengan & Jing Zeng. (2020) Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes. Advances in Radiation Oncology 5:3, pages 434-443.
Crossref
Crossref
Ayumi Taguchi, Akiko Furusawa, Kei Ito, Yujiro Nakajima, Takuya Shimizuguchi, Konan Hara, Maki Takao, Tomoko Kashiyama, Nao Kino, Katsuyuki Karasawa & Toshiharu Yasugi. (2020) Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study. International Journal of Clinical Oncology 25:5, pages 955-962.
Crossref
Crossref
Andrew Brandmaier & Silvia C. Formenti. (2020) The Impact of Radiation Therapy on Innate and Adaptive Tumor Immunity. Seminars in Radiation Oncology 30:2, pages 139-144.
Crossref
Crossref
Philippe Lambin, Relinde I.Y. Lieverse, Franziska Eckert, Damiënne Marcus, Cary Oberije, Alexander M.A. van der Wiel, Chandan Guha, Ludwig J. Dubois & Joseph O. Deasy. (2020) Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy. Seminars in Radiation Oncology 30:2, pages 187-193.
Crossref
Crossref
Abdelkhalek Hammi, Harald Paganetti & Clemens Grassberger. (2020) 4D blood flow model for dose calculation to circulating blood and lymphocytes. Physics in Medicine & Biology 65:5, pages 055008.
Crossref
Crossref
Duoying Wang, Dong Guo, Aijie Li, Peiliang Wang, Feifei Teng & Jinming Yu. (2020) The post-treatment neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after treatment of stage III non-small-cell lung cancer with conventionally fractionated radiotherapy. Future Oncology 16:9, pages 439-449.
Crossref
Crossref
Marco Durante & Silvia Formenti. (2020) Harnessing radiation to improve immunotherapy: better with particles?. The British Journal of Radiology 93:1107, pages 20190224.
Crossref
Crossref
Jian-Yue Jin, Todd Mereniuk, Anirudh Yalamanchali, Weili Wang, Mitchell Machtay, Feng-Ming (Spring)Kong & Susannah Ellsworth. (2020) A framework for modeling radiation induced lymphopenia in radiotherapy. Radiotherapy and Oncology 144, pages 105-113.
Crossref
Crossref
Valérie Dutoit, Géraldine Philippin, Valérie Widmer, Eliana Marinari, Aurélie Vuilleumier, Denis Migliorini, Karl Schaller & Pierre-Yves Dietrich. (2020) Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients. Frontiers in Oncology 10.
Crossref
Crossref
Cong Zhu, Steven H Lin, Xiaoqian Jiang, Yang Xiang, Zayne Belal, Goo Jun & Radhe Mohan. (2020) A novel deep learning model using dosimetric and clinical information for grade 4 radiotherapy-induced lymphopenia prediction. Physics in Medicine & Biology 65:3, pages 035014.
Crossref
Crossref
Qianqian Zhao, Tingting Li, Gang Chen, Zhaochong Zeng & Jian He. (2020) Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy. Frontiers in Oncology 9.
Crossref
Crossref
Eudocia Q Lee, Michael Weller, Joohee Sul, Stephen J Bagley, Solmaz Sahebjam, Martin van den Bent, Manmeet Ahluwalia, Jian L Campian, Evanthia Galanis, Mark R Gilbert, Matthias Holdhoff, Glenn J Lesser, Frank S Lieberman, Minesh P Mehta, Marta Penas-Prado, Karisa C Schreck, Roy E Strowd, Michael A Vogelbaum, Tobias Walbert, Susan M Chang, L Burt Nabors, Stuart Grossman, David A Reardon & Patrick Y Wen. (2020) Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients. Neuro-Oncology.
Crossref
Crossref
Joseph D. Wilson, Ester M. Hammond, Geoff S. Higgins & Kristoffer Petersson. (2020) Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?. Frontiers in Oncology 9.
Crossref
Crossref
Xin Wang, Peiliang Wang, Zongxing Zhao, Qingfeng Mao, Jinming Yu & Minghuan Li. (2020) A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy. Therapeutic Advances in Medical Oncology 12, pages 175883592092682.
Crossref
Crossref
Joris B.W. Elbers, Abrahim Al-Mamgani, Margot E.T. Tesseslaar, Michiel W.M. van den Brekel, Charlotte A.H. Lange, Jacqueline E. van der Wal, Marcel Verheij, Charlotte L. Zuur & Jan Paul de Boer. (2020) Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial. Radiotherapy and Oncology 142, pages 79-84.
Crossref
Crossref
Peter S.N. van Rossum, Wei Deng, David M. Routman, Amy Y. Liu, Cai Xu, Yutaka Shiraishi, Max Peters, Kenneth W. Merrell, Christopher L. Hallemeier, Radhe Mohan & Steven H. Lin. (2020) Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram. Practical Radiation Oncology 10:1, pages e16-e26.
Crossref
Crossref
Stephen Ahn, Jae-Sung Park, Jinhee Jang, Kook-Jin Ahn, Yong-Kil Hong, Seung Ho Yang & Sin-Soo Jeun. (2020) The association between total lymphocyte count after concomitant chemoradiation and overall survival in patients with newly diagnosed glioblastoma. Journal of Clinical Neuroscience 71, pages 21-25.
Crossref
Crossref
Jeremy Brownstein, Hooney D. Min, Marc Bussiere & Helen A. Shih. 2020. Radiotherapy in Managing Brain Metastases. Radiotherapy in Managing Brain Metastases
185
196
.
Sri Mutya Sekarutami & Handoko. (2019) The future of radiotherapy and immunotherapy concomitantly in cancer management. Medical Journal of Indonesia 28:4, pages 391-5.
Crossref
Crossref
Elena Garelli, Achim Rittmeyer, Paul Martin Putora, Markus Glatzer, Ralf Dressel & Stefan Andreas. (2019) Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy 11:17, pages 1445-1461.
Crossref
Crossref
Xin Wang, Gaochao Guo, Hui Guan, Yang Yu, Jie Lu & Jinming Yu. (2019) Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Qianqian Zhao, Gang Chen, Luxi Ye, Shiming Shi, Shisuo Du, Zhaochong Zeng & Jian He. (2019) Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC. Radiation Oncology 14:1.
Crossref
Crossref
Hwa Kyung Byun, Nalee Kim, Hong In Yoon, Seok-Gu Kang, Se Hoon Kim, Jaeho Cho, Jong Geol Baek, Jong Hee Chang & Chang-Ok Suh. (2019) Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era. Radiation Oncology 14:1.
Crossref
Crossref
Giuseppe Sanguineti, Diana Giannarelli, Maria Grazia Petrongari, Stefano Arcangeli, Angelo Sangiovanni, Biancamaria Saracino, Alessia Farneti, Adriana Faiella, Mario Conte & Giorgio Arcangeli. (2019) Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study. Radiation Oncology 14:1.
Crossref
Crossref
Guangyin Wu, Michael J. Baine, Nan Zhao, Sicong Li, Xiaobo Li & Chi Lin. (2019) Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer. BMC Cancer 19:1.
Crossref
Crossref
John P. Plastaras, Elise A. Chong & Stephen J. Schuster. (2019) Don't Get Stuck on the Shoulder: Radiation Oncologists Should Get Into the CAR With T-Cell Therapies. International Journal of Radiation Oncology*Biology*Physics 105:5, pages 1022-1024.
Crossref
Crossref
Yeona Cho, Sangjoon Park, Hwa Kyung Byun, Chang Geol Lee, Jaeho Cho, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sinae Kim, Juyoung Park & Hong In Yoon. (2019) Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 105:5, pages 1065-1073.
Crossref
Crossref
Shervin Tabrizi, Susan McDuff & Alice Y. Ho. (2019) Combining Radiation Therapy with Immune Checkpoint Blockadein Breast Cancer. Current Breast Cancer Reports 11:4, pages 203-216.
Crossref
Crossref
Mathieu Spaas & Yolande Lievens. (2019) Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?. Frontiers in Medicine 6.
Crossref
Crossref
Susannah G. Ellsworth, Anirudh Yalamanchali, Hong Zhang, Stuart A. Grossman, Robert Hobbs & Jian-Yue Jin. (2019) Comprehensive Analysis of the Kinetics of Radiation-Induced Lymphocyte Loss in Patients Treated with External Beam Radiation Therapy. Radiation Research 193:1, pages 73.
Crossref
Crossref
Alexander J. Lin, Farrokh Dehdashti & Perry W. Grigsby. (2019) Molecular Imaging for Radiotherapy Planning and Response Assessment for Cervical Cancer. Seminars in Nuclear Medicine 49:6, pages 493-500.
Crossref
Crossref
Cynthia Terrones-Campos, Bruno Ledergerber, Ivan Richter Vogelius, Lena Specht, Marie Helleberg & Jens Lundgren. (2019) Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 105:4, pages 812-823.
Crossref
Crossref
Hwa Kyung Byun, Nalee Kim, Sangjoon Park & Jinsil Seong. (2019) Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinomaAkute schwere Lymphopenie durch Strahlentherapie ist beim hepatozellulären Karzinom mit reduziertem Gesamtüberleben assoziiert. Strahlentherapie und Onkologie 195:11, pages 1007-1017.
Crossref
Crossref
Hai-Ge Zhang, Ping Yang, Tao Jiang, Jian-Ying Zhang, Xue-Juan Jin, Yong Hu, Jing Sun, Shi-Suo Du & Zhao-Chong Zeng. (2019) Lymphopenia Is Associated with Gross Target Volumes and Fractions in Hepatocellular Carcinoma Patients Treated with External Beam Radiation Therapy and Also Indicates Worse Overall Survival. Canadian Journal of Gastroenterology and Hepatology 2019, pages 1-12.
Crossref
Crossref
Lawrence Kleinberg, Lindsey Sloan, Stuart Grossman & Michael Lim. (2019) Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy. Neurosurgery 85:4, pages 441-453.
Crossref
Crossref
Eun Young Park, Yeon-Sil Kim, Kyu Hye Choi, Jin Ho Song, Hyo Chun Lee, Sook-Hee Hong & Jin-Hyoung Kang. (2019) Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. Radiation Oncology Journal 37:3, pages 166-175.
Crossref
Crossref
Yuan Zhuang, Bao-ying Yuan, Gen-wen Chen, Xiao-mei Zhao, Yong Hu, Wen-chao Zhu, Zhao-chong Zeng & Yi-xing Chen. (2019) Association Between Circulating Lymphocyte Populations and Outcome After Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma. Frontiers in Oncology 9.
Crossref
Crossref
Qiaoqiao Li, Sha Zhou, Shiliang Liu, Songran Liu, Hong Yang, Lei Zhao, Mengzhong Liu, Yonghong Hu & Mian Xi. (2019) Treatment-Related Lymphopenia Predicts Pathologic Complete Response and Recurrence in Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemoradiotherapy. Annals of Surgical Oncology 26:9, pages 2882-2889.
Crossref
Crossref
Xi-Lei Zhou, Wei-Guo Zhu, Zhi-Jian Zhu, Wan-Wei Wang, Xue Deng, Wei-Jing Tao, Fu-Zhi Ji & Yu-Suo Tong. (2019) Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy. The Oncologist 24:8, pages e677-e686.
Crossref
Crossref
Boustani, Grapin, Laurent, Apetoh & Mirjolet. (2019) The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune Response. Cancers 11:6, pages 860.
Crossref
Crossref
Nuradh Joseph, Alan McWilliam, Jason Kennedy, Kate Haslett, Jasmin Mahil, Abhilash Gavarraju, Hitesh Mistry, Marcel Van Herk, Corinne Faivre-Finn & Ananya Choudhury. (2019) Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy. Radiotherapy and Oncology 135, pages 115-119.
Crossref
Crossref
Woo Jin Kim, Yun-Sik Dho, Chan-Young Ock, Jin Wook Kim, Seung Hong Choi, Soon-Tae Lee, Il Han Kim, Tae Min Kim & Chul-Kee Park. (2019) Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma. Journal of Neuro-Oncology 143:2, pages 321-328.
Crossref
Crossref
Lu‐Lu Ye, Xing‐Wen Fan, Chao‐Su Hu, Xia‐Yun He, Xiao‐Shen Wang, Chun‐Ying Shen, Ting‐Ting Xu & Hong‐Mei Ying. (2019) Dosimetry of the brain and hypothalamus predicting acute lymphopenia and the survival of glioma patients with postoperative radiotherapy. Cancer Medicine 8:6, pages 2759-2768.
Crossref
Crossref
Alexander J. Lin, Margery Gang, Yuan James Rao, Jian Campian, Mackenzie Daly, Hiram Gay, Peter Oppelt, Ryan S. Jackson, Jason Rich, Randal Paniello, Jose Zevallos, Dennis Hallahan, Douglas Adkins & Wade Thorstad. (2019) Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus–Negative Oropharyngeal Cancers. JAMA Otolaryngology–Head & Neck Surgery 145:5, pages 413.
Crossref
Crossref
Chul Won Choi, Min Ho Jeong, You-Soo Park, Cheol-Hun Son, Hong-Rae Lee & Eun-Kyoung Koh. (2019) Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects. Cancer Research and Treatment 51:2, pages 464-473.
Crossref
Crossref
Jacob S. Young, Fara Dayani, Ramin A. Morshed, Hideho Okada & Manish K. Aghi. (2019) Immunotherapy for High-Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons. World Neurosurgery 124, pages 397-409.
Crossref
Crossref
Wei Deng, Cai Xu, Amy Liu, Peter S.N. van Rossum, Weiye Deng, Zhongxing Liao, Albert C. Koong, Radhe Mohan & Steven H. Lin. (2019) The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy. Radiotherapy and Oncology 133, pages 9-15.
Crossref
Crossref
Michael D. Schad, Sunil W. Dutta, Donald M. Muller, Krishni Wijesooriya & Timothy N. Showalter. (2019) Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer. Advances in Radiation Oncology 4:2, pages 323-330.
Crossref
Crossref
Jean Philippe Nesseler, Dorthe Schaue, William H. McBride, Mi-Heon Lee, Tania Kaprealian, Simone P. Niclou & Philippe Nickers. (2019) Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas. Advances in Radiation Oncology 4:2, pages 268-282.
Crossref
Crossref
Karishma R. Rajani, Lucas P. Carlstrom, Ian F. Parney, Aaron J. Johnson, Arthur E. Warrington & Terry C. Burns. (2019) Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma. Frontiers in Oncology 8.
Crossref
Crossref
Maxime Fontanilles, Florent Marguet, Cristina Alexandru, Olivier Langlois, Ovidiu Veresezan, Vianney Gilard, Marion David, Annie Laquerriere, Chantal Hanzen, Isabelle Tennevet, Frédéric Di Fiore & Florian Clatot. (2018) Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients. Supportive Care in Cancer 27:2, pages 477-484.
Crossref
Crossref
Pavlina Chuntova, Kira M. Downey, Bindu Hegde, Neil D. Almeida & Hideho Okada. (2019) Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy. Frontiers in Immunology 9.
Crossref
Crossref
Jing Cheng, Yanqin Fan, Gang Deng, Baohui Liu, Junmin Wang & Qianxue Chen. (2019) Levels of peripheral immune blood cells are related to the grade of isocitrate dehydrogenase-mutant oligodendroglioma. Glioma 2:4, pages 174.
Crossref
Crossref
Stephanie M. Lewkiewicz, Yao-Li Chuang & Tom Chou. (2019) Dynamics of T cell receptor distributions following acute thymic atrophy and resumption. Mathematical Biosciences and Engineering 17:1, pages 28-55.
Crossref
Crossref
Sangjoon Park, Hwa Kyung Byun & Jinsil Seong. (2019) Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular Carcinoma. Liver Cancer 8:6, pages 468-479.
Crossref
Crossref
Luke R.G. Pike, Andrew Bang, Brandon A. Mahal, Allison Taylor, Monica Krishnan, Alexander Spektor, Daniel N. Cagney, Ayal A. Aizer, Brian M. Alexander, Osama Rahma, Tracy Balboni, Patrick A. Ott, F. Stephen Hodi & Jonathan D. Schoenfeld. (2019) The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors. International Journal of Radiation Oncology*Biology*Physics 103:1, pages 142-151.
Crossref
Crossref
David M. Routman, Aurelie Garant, Scott C. Lester, Courtney N. Day, William S. Harmsen, Cristobal T. Sanheuza, Harry H. Yoon, Michelle A. Neben-Wittich, James A. Martenson, Michael G. Haddock, Christopher L. Hallemeier & Kenneth W. Merrell. (2019) A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer. Advances in Radiation Oncology 4:1, pages 63-69.
Crossref
Crossref
Sherise D. Ferguson, Shiao-Pei Weathers & Amy B. Heimberger. 2019. Oligodendroglioma. Oligodendroglioma
387
396
.
Talicia Savage & Chandan Guha. 2019. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy
15
29
.
Displaying 200 of 262 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list